Ovintiv Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Ovintiv Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||||
net earnings | 466,000,000 | -159,000,000 | 618,000,000 | 167,000,000 | 2,000,000 | 338,000,000 | 1,679,000,000 | 70,000,000 | -151,000,000 | 487,000,000 | 2,451,000,000 | -171,000,000 | 1,598,000,000 | -241,000,000 | 1,488,000,000 | 133,000,000 | -514,000,000 | 309,000,000 | -4,576,000,000 | 421,000,000 |
depreciation, depletion and amortization | 11,000,000 | 545,000,000 | 1,691,000,000 | 19,000,000 | 14,000,000 | 566,000,000 | 1,339,000,000 | 67,000,000 | 55,000,000 | 364,000,000 | 822,000,000 | 13,000,000 | 14,000,000 | 264,000,000 | 893,000,000 | -14,000,000 | 3,000,000 | 308,000,000 | 1,428,000,000 | 534,000,000 |
impairments | 730,000,000 | 4,244,000,000 | 277,000,000 | |||||||||||||||||
accretion of asset retirement obligation | 2,000,000 | 6,000,000 | 14,000,000 | 1,000,000 | -1,000,000 | 5,000,000 | 14,000,000 | 1,000,000 | -1,000,000 | 5,000,000 | 14,000,000 | -1,000,000 | 0 | 5,000,000 | 17,000,000 | -1,000,000 | 0 | 6,000,000 | 21,000,000 | 9,000,000 |
deferred income taxes | 143,000,000 | -77,000,000 | 123,000,000 | -82,000,000 | 45,000,000 | 58,000,000 | 222,000,000 | -125,000,000 | -17,000,000 | 64,000,000 | -175,000,000 | 30,000,000 | 66,000,000 | -8,000,000 | -22,000,000 | -20,000,000 | 423,000,000 | 140,000,000 | ||
unrealized (gain) loss on risk management | -100,000,000 | 46,000,000 | 167,000,000 | -23,000,000 | -108,000,000 | 100,000,000 | -486,000,000 | 434,000,000 | -124,000,000 | -18,000,000 | -31,000,000 | -197,000,000 | -1,525,000,000 | 1,012,000,000 | -91,000,000 | 3,000,000 | 305,000,000 | 271,000,000 | -39,000,000 | -904,000,000 |
unrealized foreign exchange (gain) loss | 47,000,000 | -45,000,000 | 19,000,000 | 21,000,000 | 18,000,000 | -23,000,000 | 13,000,000 | -29,000,000 | 15,000,000 | -5,000,000 | -6,000,000 | 13,000,000 | 10,000,000 | -3,000,000 | 7,000,000 | 10,000,000 | 2,000,000 | 2,000,000 | 32,000,000 | 101,000,000 |
foreign exchange (gain) loss on settlements | 43,000,000 | -42,000,000 | -40,000,000 | 3,000,000 | -3,000,000 | -2,000,000 | 4,000,000 | |||||||||||||
other | 22,000,000 | -153,000,000 | 23,000,000 | -7,000,000 | 2,000,000 | -3,000,000 | 66,000,000 | -45,000,000 | 91,000,000 | 25,000,000 | 17,000,000 | 15,000,000 | 80,000,000 | -20,000,000 | 24,000,000 | 20,000,000 | -10,000,000 | -63,000,000 | ||
net change in other assets and liabilities | 0 | -11,000,000 | -93,000,000 | 61,000,000 | -30,000,000 | -12,000,000 | -48,000,000 | -2,000,000 | -7,000,000 | -5,000,000 | -40,000,000 | -4,000,000 | -1,000,000 | -12,000,000 | -29,000,000 | -5,000,000 | 1,000,000 | -6,000,000 | -126,000,000 | -52,000,000 |
net change in non-cash working capital | 231,000,000 | -120,000,000 | -272,000,000 | -12,000,000 | 401,000,000 | -364,000,000 | 522,000,000 | -336,000,000 | -78,000,000 | 222,000,000 | -218,000,000 | -102,000,000 | 479,000,000 | -346,000,000 | -18,000,000 | -45,000,000 | 79,000,000 | -57,000,000 | -3,000,000 | 83,000,000 |
cash from operating activities | 140,000,000 | 873,000,000 | 2,699,000,000 | 2,000,000 | 361,000,000 | 659,000,000 | 3,261,000,000 | 75,000,000 | -237,000,000 | 1,068,000,000 | 2,904,000,000 | -382,000,000 | 659,000,000 | 685,000,000 | 2,317,000,000 | 62,000,000 | -77,000,000 | 827,000,000 | 1,402,000,000 | 566,000,000 |
investing activities | ||||||||||||||||||||
capital expenditures | 96,000,000 | -617,000,000 | -1,765,000,000 | 84,000,000 | -31,000,000 | -591,000,000 | -1,910,000,000 | -194,000,000 | -30,000,000 | -610,000,000 | -1,320,000,000 | 0 | -60,000,000 | -451,000,000 | -1,154,000,000 | 18,000,000 | -33,000,000 | -350,000,000 | -1,385,000,000 | -790,000,000 |
free cash flows | 236,000,000 | 256,000,000 | 934,000,000 | 86,000,000 | 330,000,000 | 68,000,000 | 1,351,000,000 | -119,000,000 | -267,000,000 | 458,000,000 | 1,584,000,000 | -382,000,000 | 599,000,000 | 234,000,000 | 1,163,000,000 | 80,000,000 | -110,000,000 | 477,000,000 | 17,000,000 | -224,000,000 |
acquisitions | 2,307,000,000 | -2,310,000,000 | -198,000,000 | -2,000,000 | 185,000,000 | -190,000,000 | -218,000,000 | -44,000,000 | 184,000,000 | -199,000,000 | -274,000,000 | -5,000,000 | 8,000,000 | -15,000,000 | -1,000,000 | -1,000,000 | -18,000,000 | -17,000,000 | ||
corporate acquisition | 12,000,000 | |||||||||||||||||||
proceeds from divestitures | -1,872,000,000 | 1,884,000,000 | 160,000,000 | 1,000,000 | 0 | 2,000,000 | 760,000,000 | -705,000,000 | 705,000,000 | 12,000,000 | 3,000,000 | 221,000,000 | 3,000,000 | 1,000,000 | 1,033,000,000 | -1,031,000,000 | 1,021,000,000 | 2,000,000 | 50,000,000 | 22,000,000 |
net change in investments and other | -194,000,000 | 148,000,000 | -150,000,000 | 42,000,000 | -22,000,000 | 6,000,000 | -72,000,000 | -128,000,000 | 221,000,000 | -66,000,000 | 69,000,000 | 48,000,000 | -26,000,000 | 76,000,000 | -98,000,000 | 28,000,000 | -266,000,000 | 130,000,000 | ||
cash from investing activities | 337,000,000 | -895,000,000 | -1,941,000,000 | 125,000,000 | 120,000,000 | -761,000,000 | -4,665,000,000 | 2,154,000,000 | -2,145,000,000 | -863,000,000 | -1,522,000,000 | 250,000,000 | -97,000,000 | -417,000,000 | -158,000,000 | -935,000,000 | 889,000,000 | -321,000,000 | -1,619,000,000 | -655,000,000 |
financing activities | ||||||||||||||||||||
net issuance (repayment) of revolving debt | 311,000,000 | 85,000,000 | -74,000,000 | -99,000,000 | -572,000,000 | 461,000,000 | -138,000,000 | |||||||||||||
repayment of long-term debt | -1,109,000,000 | 578,000,000 | -1,097,000,000 | -6,000,000 | -619,000,000 | 101,000,000 | -163,000,000 | -89,000,000 | ||||||||||||
purchase of shares of common stock | -434,000,000 | 21,000,000 | 66,000,000 | -250,000,000 | -381,000,000 | 44,000,000 | 150,000,000 | -239,000,000 | -394,000,000 | -190,000,000 | -64,000,000 | -71,000,000 | ||||||||
dividends on shares of common stock | 1,000,000 | -78,000,000 | -238,000,000 | 2,000,000 | 0 | -80,000,000 | -225,000,000 | 0 | -21,000,000 | -61,000,000 | -177,000,000 | 2,000,000 | -12,000,000 | -52,000,000 | -85,000,000 | -12,000,000 | -1,000,000 | -24,000,000 | -73,000,000 | -24,000,000 |
finance lease payments and other | 17,000,000 | -19,000,000 | -32,000,000 | -1,000,000 | 28,000,000 | -29,000,000 | -74,000,000 | -2,000,000 | 70,000,000 | -71,000,000 | -67,000,000 | 0 | 62,000,000 | -64,000,000 | -97,000,000 | 71,000,000 | ||||
cash from financing activities | -418,000,000 | -12,000,000 | -778,000,000 | -77,000,000 | -478,000,000 | 102,000,000 | 1,460,000,000 | -2,307,000,000 | 2,390,000,000 | -184,000,000 | -1,579,000,000 | 400,000,000 | -896,000,000 | -193,000,000 | -1,862,000,000 | 650,000,000 | -700,000,000 | -507,000,000 | 50,000,000 | 9,000,000 |
foreign exchange gain on cash, cash equivalents | ||||||||||||||||||||
and restricted cash held in foreign currency | 8,000,000 | 2,000,000 | -3,000,000 | 5,000,000 | -5,000,000 | 1,000,000 | -4,000,000 | -6,000,000 | -7,000,000 | |||||||||||
increase in cash, cash equivalents and restricted cash | 46,000,000 | -34,000,000 | -12,000,000 | 48,000,000 | 1,000,000 | 2,000,000 | 47,000,000 | -75,000,000 | 5,000,000 | 21,000,000 | -200,000,000 | 273,000,000 | -339,000,000 | 76,000,000 | 299,000,000 | -227,000,000 | 114,000,000 | -1,000,000 | -173,000,000 | -87,000,000 |
cash, cash equivalents and restricted cash, beginning of period | 3,000,000 | 26,000,000 | -263,000,000 | 113,000,000 | ||||||||||||||||
cash, cash equivalents and restricted cash, end of period | 12,000,000 | 8,000,000 | 51,000,000 | 3,000,000 | 5,000,000 | -49,000,000 | 26,000,000 | 26,000,000 | 10,000,000 | -263,000,000 | 271,000,000 | -114,000,000 | 113,000,000 | 9,000,000 | 103,000,000 | |||||
cash, end of period | 12,000,000 | 7,000,000 | 3,000,000 | 3,000,000 | 3,000,000 | -6,000,000 | 3,000,000 | 6,000,000 | 4,000,000 | -40,000,000 | 48,000,000 | -60,000,000 | 59,000,000 | 8,000,000 | 35,000,000 | |||||
cash equivalents, end of period | 0 | 1,000,000 | 0 | 2,000,000 | 23,000,000 | 20,000,000 | 223,000,000 | -54,000,000 | 54,000,000 | 1,000,000 | 47,000,000 | |||||||||
restricted cash, end of period | 21,000,000 | |||||||||||||||||||
supplementary cash flow information | ||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of year | 42,000,000 | 3,000,000 | 5,000,000 | 195,000,000 | 10,000,000 | 190,000,000 | ||||||||||||||
corporate acquisition, net of cash acquired | ||||||||||||||||||||
issuance of long-term debt | ||||||||||||||||||||
cash, cash equivalents and restricted cash, end of year | ||||||||||||||||||||
cash, end of year | ||||||||||||||||||||
cash equivalents, end of year | ||||||||||||||||||||
restricted cash, end of year | ||||||||||||||||||||
foreign exchange on settlements | 5,000,000 | -1,000,000 | -1,000,000 | -8,000,000 | 0 | 3,000,000 | -6,000,000 | 8,000,000 | 20,000,000 | |||||||||||
net issuance (repayment) of revolving long-term debt | -87,000,000 | 187,000,000 | 168,000,000 | 10,000,000 | -30,000,000 | -460,000,000 | 352,000,000 | 144,000,000 | ||||||||||||
(gain) loss on divestitures | ||||||||||||||||||||
corporate acquisition, net of cash and restricted cash acquired | ||||||||||||||||||||
finance lease payments | -23,000,000 | |||||||||||||||||||
finance lease payments and other financing arrangements | -66,000,000 | -22,000,000 | ||||||||||||||||||
purchase of common shares | ||||||||||||||||||||
dividends on common shares |
We provide you with 20 years of cash flow statements for Ovintiv stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ovintiv stock. Explore the full financial landscape of Ovintiv stock with our expertly curated income statements.
The information provided in this report about Ovintiv stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.